MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/metabo15120786

Медицинская библиотека · Metabolites · 2025

Multi-Omics Characterization of a Novel SSR4 Variant in Congenital Disorders of Glycosylation.

Abu Bakar Nurulamin, Hamzan Nurul Izzati, Majawit Elyssa Milus, Ahmad Ridzuan Siti Nurwani, Hassan Noor Hafizah, Habib Anasufiza, Ngu Lock-Hock

Клинический случайСтатьяПеревод в очереди

Аннотация

Background

Congenital disorders of glycosylation (CDG) are rare inborn errors of metabolism with multisystemic manifestations. SSR4-CDG is an ultra-rare X-linked subtype caused by pathogenic variants in SSR4, a component of the translocon-associated protein (TRAP) complex essential for protein translocation and N-glycosylation. Case presentation: We report a two-year-old Malaysian male presenting with global developmental delay, central hypotonia, microcephaly with complete agenesis of the corpus callosum, recurrent infections, bilateral vesicoureteral reflux, and failure to thrive. Growth parameters (weight, length, and head circumference) were persistently below the expected percentiles, indicating postnatal growth restriction. Initial metabolic and biochemical investigations for global developmental delay were unremarkable, apart from mild hyperammonemia. Transferrin isoform analysis demonstrated a type I CDG pattern, raising suspicion of a glycosylation defect.

Results

Transferrin glycopeptide LC-MS/MS showed impaired N-glycan occupancy at both glycosylation sites (Asn432 and Asn630), with reduced fully sialylated glycoforms and increased non-glycosylated peptides. Targeted metabolomics using triple quadrupole LC-MS/MS revealed systemic abnormalities, including elevated arginine and phenylalanine, reduced glutamate, increased lysophosphatidylcholine (C24:0-LPC), and generalized depletion of free and acylcarnitines. Whole-exome sequencing identified a novel hemizygous SSR4 variant (c.98del; p.Pro33LeufsTer23) on the X chromosome, predicted to produce a truncated, nonfunctional protein.

Conclusions

This is the first Malaysian patient with SSR4-CDG, comprehensively characterized using a multi-omics diagnostic workflow. The integration of glycoproteomics, metabolomics, and exome sequencing provided a detailed biochemical fingerprint that expands the clinical, genetic, and metabolic spectrum of SSR4-CDG and demonstrates the diagnostic and translational value of multi-omics approaches in inborn errors of metabolism.

Для цитирования: Abu Bakar Nurulamin, Hamzan Nurul Izzati, Majawit Elyssa Milus, Ahmad Ridzuan Siti Nurwani, Hassan Noor Hafizah, Habib Anasufiza, Ngu Lock-Hock. Multi-Omics Characterization of a Novel SSR4 Variant in Congenital Disorders of Glycosylation.. Metabolites. 2025. DOI: 10.3390/metabo15120786.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.